GAZZINA, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.345
EU - Europa 589
AS - Asia 283
OC - Oceania 5
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.225
Nazione #
US - Stati Uniti d'America 1.340
CN - Cina 137
DE - Germania 136
IT - Italia 120
UA - Ucraina 85
HK - Hong Kong 84
FI - Finlandia 63
GB - Regno Unito 59
SG - Singapore 46
IE - Irlanda 41
FR - Francia 26
RU - Federazione Russa 19
CZ - Repubblica Ceca 17
PL - Polonia 14
AU - Australia 5
IN - India 5
CA - Canada 4
SE - Svezia 4
TR - Turchia 4
BE - Belgio 2
BR - Brasile 2
IR - Iran 2
NL - Olanda 2
VN - Vietnam 2
AT - Austria 1
DO - Repubblica Dominicana 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
SA - Arabia Saudita 1
Totale 2.225
Città #
Fairfield 197
Ashburn 113
Woodbridge 105
Houston 97
Chandler 88
New York 85
Hong Kong 84
Jacksonville 69
Cambridge 68
Seattle 63
Helsinki 61
Wilmington 58
Princeton 55
Dearborn 53
Dublin 41
Brescia 35
Nanjing 24
Shanghai 24
Singapore 23
Los Angeles 22
Ann Arbor 19
Boardman 18
Beijing 17
Olomouc 14
Warsaw 14
Milan 13
San Diego 12
Changsha 9
Hebei 9
Norwalk 9
Shenyang 9
Des Moines 8
Jinan 8
Nanchang 8
Rome 7
Lancaster 6
London 6
Honolulu 5
Washington 5
Augusta 4
Orzinuovi 4
Arezzo 3
Avigliana 3
Brno 3
Chiswick 3
Guangzhou 3
Haikou 3
Hounslow 3
Islington 3
Kocaeli 3
New Bedfont 3
Ningbo 3
Nürnberg 3
Redwood City 3
Rio Saliceto 3
Toronto 3
Belluno 2
Bienno 2
Brussels 2
Calcio 2
Dong Ket 2
Falkenstein 2
Gunzenhausen 2
Hangzhou 2
Jiaxing 2
Kilburn 2
Kunming 2
La Seyne-sur-Mer 2
Leipzig 2
Melbourne 2
Munich 2
New Delhi 2
Perth 2
San Francisco 2
Taiyuan 2
Taizhou 2
Tesero 2
Tianjin 2
Torino 2
Verona 2
Zhengzhou 2
Albino 1
Barlassina 1
Berlin 1
Catania 1
Chester 1
Chicago 1
Clifton 1
Cremona 1
Faggiano 1
Frankfurt am Main 1
Hefei 1
Jakarta 1
Lanzhou 1
Lappeenranta 1
Leawood 1
Magdeburg 1
Mantova 1
Markham 1
Monmouth Junction 1
Totale 1.683
Nome #
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 155
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 152
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 144
COVID-19 impact on consecutive neurological patients admitted to the emergency department 141
Autoimmunity and frontotemporal dementia 119
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 110
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 106
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 102
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 99
Natural history and predictors of survival in progressive supranuclear palsy. 96
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 88
Myoclonic dystonia (DYT11) responsive to insulin therapy: A case report. 85
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 79
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 72
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 44
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 41
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 39
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 39
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 34
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 34
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 33
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 33
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 31
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 31
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 28
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 28
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 27
Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study 26
Differential early subcortical involvement in genetic FTD within the GENFI cohort 25
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 24
Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration 24
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 24
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration 23
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 23
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 21
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 21
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 20
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 18
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease 17
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 15
QEEG abnormalities in cognitively unimpaired patients with delirium 12
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis 11
Sex-differences in the longitudinal recovery of neuromuscular function in COVID-19 associated acute respiratory distress syndrome survivors 10
Electrophysiological neuromuscular alterations and severe fatigue predict long-term muscle weakness in survivors of COVID-19 acute respiratory distress syndrome 9
Totale 2.313
Categoria #
all - tutte 17.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020403 0 0 21 45 36 66 66 51 36 50 8 24
2020/2021448 15 34 14 32 64 69 12 32 56 49 52 19
2021/2022251 17 24 5 4 1 17 25 21 17 38 27 55
2022/2023322 29 11 22 12 31 84 8 26 46 2 24 27
2023/2024511 32 16 65 33 14 116 15 21 89 22 5 83
2024/202518 7 11 0 0 0 0 0 0 0 0 0 0
Totale 2.313